4//SEC Filing
STEINMAN LAWRENCE 4
Accession 0001213900-23-045386
CIK 0001690080other
Filed
Jun 1, 8:00 PM ET
Accepted
Jun 2, 8:00 AM ET
Size
5.2 KB
Accession
0001213900-23-045386
Insider Transaction Report
Form 4
STEINMAN LAWRENCE
Director
Transactions
- Purchase
Common Stock
2023-06-01$1.23/sh+18,000$22,068→ 48,129 total
Footnotes (1)
- [F1]This transaction was executed in multiple trades at prices ranging from $1.15 to $1.26. The price reported above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001132679
Filing Metadata
- Form type
- 4
- Filed
- Jun 1, 8:00 PM ET
- Accepted
- Jun 2, 8:00 AM ET
- Size
- 5.2 KB